Mylan Pharmaceuticals Inc. et al. vs. Boehringer Ingelheim Pharmaceuticals Inc. et al.
Explore the PTAB proceeding IPR2016-01566 filed by Mylan Pharmaceuticals Inc. et al. on 2016-08-10. This includes filing dates, application numbers, tech centers, patent numbers, and current case status.
Proceeding Overview
Proceeding Number
IPR2016-01566
Filing Date
2016-08-10
Accorded Filing Date
2016-08-10
Institution Decision Date
2017-02-03
Last Modified Date
2022-10-10
Proceeding Type
IPR
Termination Date
โ
Trial Status
Institution Denied
Parties & Counsel
Petitioner
Mylan Pharmaceuticals Inc. et al.
Represented By
Parker, Thomaset alPatent Owner / Respondent
Patent Information
Tribunal & APJ Panel Intelligence
Tribunal
Patent Trial and Appeal Board (USPTO)
Technology Center
TC 1600 - Biotechnology & Organic Chemistry
Decisions Rendered
1 Total
Proceeding Status
Institution Denied
Administrative Patent Judges (APJ Panel)
Board Decisions & Rulings (1)
Address and Attorney/Agent Information
Power of Attorney & Correspondence
Attorney / Agent Information
| Reg # | Name | Phone |
|---|---|---|
| 37933 | Suzanne Shope | +1 678-638-3053 |
| 41482 | Philip Datlow | +1 203-798-4542 |
| 43512 | Mary Smith | +1 203-448-1532 |
| 46124 | David Dow | +1 203-791-6214 |
| 51962 | Andrea Lockenour | +1 203-798-4710 |
| 53081 | Shelley Jones | +1 203-205-7459 |
| 53112 | David Kershner | +1 203-798-5469 |
| 53785 | Paula Wittmayer | +1 203-791-6692 |
Global Patent Family Cross-Litigation Radar
CasLoc 360ยฐ Radar 10 Family MembersMulti-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions
| Jurisdiction | Publication Number | Relationship | Official Record |
|---|---|---|---|
| ๐บ๐ธ United States | US 9,173,859 B2 Asserted | US Continuation / Sibling | View Official Patent → |
| ๐บ๐ธ United States | US 2016000079 | US Continuation / Sibling | View Official Patent → |
| ๐บ๐ธ United States | US 10,080,754 B2 | US Continuation / Sibling | View Official Patent → |
| ๐บ๐ธ United States | US 2018035351 | US Continuation / Sibling | View Official Patent → |
| ๐บ๐ธ United States | US 11,291,668 B2 | US Continuation / Sibling | View Official Patent → |
| ๐บ๐ธ United States | US 12,171,767 B2 | US Continuation / Sibling | View Official Patent → |
| ๐บ๐ธ United States | US 2025006481 | US Continuation / Sibling | View Official Patent → |
| ๐ช๐บ European Patent Office (UPC States) | EP 6,009,203 | European Counterpart (EP) | View Official Patent → |
| ๐บ๐ธ United States | US 8,232,281 B2 | US Continuation / Sibling | View Official Patent → |
| ๐บ๐ธ United States | US 8,673,927 B2 | US Continuation / Sibling | View Official Patent → |
Mylan Pharmaceuticals Inc. et al. v. Boehringer Ingelheim Pharmaceuticals Inc. et al.